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Spatial control of G-protein-coupled receptor (GPCR)
signaling, which is used by cells to translate complex
information into distinct downstream responses, is
achieved by using plasmamembrane (PM) and endo-
cytic-derived signaling pathways. The roles of the en-
domembrane in regulating such pleiotropic signaling
via multiple G-protein pathways remain unknown.
Here, we investigated the effects of disease-causing
mutations of the adaptor protein-2 s subunit (AP2s)
on signaling by the class C GPCR calcium-sensing
receptor (CaSR). These AP2s mutations increase
CaSR PM expression yet paradoxically reduce CaSR
signaling. Hypercalcemia-associated AP2s muta-
tions reduced CaSR signaling via Gaq/11 and Gai/o
pathways. Themutations also delayedCaSR internal-
ization due to prolonged residency time of CaSR
in clathrin structures that impaired or abolished endo-
somal signaling, which was predominantly mediated
by Gaq/11. Thus, compartmental bias for CaSR-
mediated Gaq/11 endomembrane signaling provides
a mechanistic basis for multidimensional GPCR
signaling.
INTRODUCTION
TheG-protein-coupled receptor (GPCR) family is the largest fam-
ily of signaling receptors, and GPCRs contribute significantly to
fundamental cellular functions. The archetypal model of GPCR
signaling has evolved from a single, cell-surface receptor acti-
vating a specific heterotrimeric G-protein pathway to a complex
network in which receptors can activate multiple pathways,
exhibit signal crosstalk, and display functional selectivity (Rose-1054 Cell Reports 22, 1054–1066, January 23, 2018 ª 2017 The Auth
This is an open access article under the CC BY license (http://creativenbaum et al., 2009). This is illustrated by the calcium-sensing
receptor (CaSR), a class C GPCR that is widely expressed
and has calcitropic roles, i.e., regulation of extracellular calcium
(Ca2+e) by the parathyroids, kidneys, and bone, and non-calci-
tropic roles such as inflammation, bronchoconstriction, wound
healing, gastro-pancreatic hormone secretion, hypertension,
and glucose metabolism (Hofer et al., 2000; Rossol et al., 2012;
Yarova et al., 2015; Zietek and Daniel, 2015). Thus, the CaSR,
which like other class C GPCRs has a large extracellular domain
(ECD) containing the ligand binding sites, a seven-transmem-
brane domain, and a large cytoplasmic C-terminal domain
(Katritchet al., 2013), formsdimersandcouples tomultipleG-pro-
tein subtypes (e.g., Gaq/11, Gai/o, Ga12/13, and Gas) to induce
diverse signaling pathways. For example, the CaSR, when stimu-
lated by elevations in Ca2+e, signals predominantly via Gaq/11 to
activate phospholipase C (PLC), with consequent hydrolysis of
phosphatidylinositol 4, 5-bisphosphate (PIP2), to thesecondmes-
sengers inositol 1, 4, 5-trisphosphate (IP3) and diacylglycerol
(DAG) (Conigrave and Ward, 2013). IP3 acts upon IP3 receptors
at the endoplasmic reticulum, allowing intracellular calcium
(Ca2+i) mobilization into the cytosol, andDAGactivates protein ki-
nase C (PKC) signaling cascades, including mitogen-activated
protein kinase (MAPK) pathways (Conigrave and Ward, 2013).
CaSR has also been reported to signal via Gai/o to inhibit
adenylate cyclase (AC)and reducecyclicAMP (cAMP) (Conigrave
and Ward, 2013), Ga12/13 to initiate cytoskeletal remodeling
(Davies et al., 2006; Huang et al., 2004), and Gas, leading to
elevated cAMP levels in breast cancer cell lines (Mamillapalli
et al., 2008).
These CaSR signaling pathways are dependent on CaSR cell-
surface expression, which is regulated by a balance between its
plasma membrane (PM) insertion and removal by endocytosis
(Grant et al., 2011). The PM insertion of CaSRs involves an anter-
ograde signaling pathway, referred to as agonist-driven inser-
tional signaling (ADIS), in which CaSRs that are continuously
produced at the endoplasmic reticulum are rapidly trafficked toor(s).
commons.org/licenses/by/4.0/).
and inserted at the PM in the presence of high Ca2+e (Grant et al.,
2011). Following activation, CaSRs have been reported to be en-
docytosed at a constant rate and targeted to the endo-lysosomal
pathway for degradation (Grant et al., 2011). However, studies
of patients with familial hypocalciuric hypercalcemia type-3
(FHH3), an autosomal dominant calcitropic disorder that is due
to mutations of the s subunit of the heterotetrameric adaptor
protein-2 (AP2s), which has a critical role in clathrin-mediated
endocytosis (Nesbit et al., 2013b), have reported that FHH3-
associated AP2s mutations result in increased expression of
the CaSR at the PM, which is paradoxically associated with
reduced CaSR signaling via Gaq/11 (Nesbit et al., 2013a). FHH
is a genetically heterogeneous disorder, which is characterized
bymild to moderate elevations in serum calcium concentrations,
low urinary calcium excretion, and normal to elevated circulating
parathyroid hormone (PTH), and the three recognized types,
FHH1, FHH2, and FHH3, are due to loss-of-function mutations
of the CaSR, Ga11, and AP2s, respectively (Hannan et al.,
2016; Nesbit et al., 2013a, 2013b). FHH3-associated AP2s mu-
tations have been found to only occur at residue R15, and these
comprise one of three missense mutations, R15C, R15H, or
R15L, all of which would lead to a loss or weakening of a polar
contact with the dileucine-based motif within cytoplasmic re-
gions of membrane-associated cargo proteins and thereby
impair their endocytosis (Kelly et al., 2008; Nesbit et al.,
2013b). In vitro studies of these FHH3-associated mutations
demonstrated that these AP2s mutations decreased CaSR-
mediated Gaq/11 signaling in response to elevations in Ca
2+
e in
cells expressing the mutants, despite increased CaSR cell-sur-
face expression (Nesbit et al., 2013b).
To explain this paradox, we hypothesized that the FHH3-asso-
ciated AP2smutations may be disrupting the contribution of en-
dosomal sustained signaling to CaSR-dependent G-protein
pathways, similar to those reported for some class A GPCRs—
e.g., b2-adrenergic receptor (b2AR), dopamine receptor D1
(DRD1), thyroid-stimulating hormone receptor (TSHR), vaso-
pressin receptor 2 (V2R), and luteinizing hormone receptor
(LHR)—and class B GPCRs (e.g., parathyroid hormone 1 recep-
tor, PTH1R) (Calebiro et al., 2009; Feinstein et al., 2013; Ferran-
don et al., 2009; Irannejad et al., 2013; Jean-Alphonse et al.,
2014; Kotowski et al., 2011). These components of the endocytic
pathway, which have previously been considered endpoints for
signaling, are now known to provide sites for sustained GPCR
signals (Feinstein et al., 2013; Ferrandon et al., 2009), although
the contribution of endomembrane sustained signaling to
GPCR function has only been studied in the context of a single
GPCR/G-protein pathway. However, GPCR signaling is com-
plex, with many receptors (e.g., the CaSR) coupling to multiple
G-protein-dependent and G-protein-independent pathways,
and strategies to pharmacologically select for such specific
pathways is increasingly recognized to be important (Rose-
nbaum et al., 2009). To further elucidate the role of the endocytic
system in coordinating the pleiotropic activities of GPCRs, we
investigated the effects of the FHH3-associated AP2smutations
on the different G-protein pathways activated by CaSR and
discovered that impaired internalization, by clathrin-mediated
endocytosis of CaSR, differentially affects G-protein pathways
of CaSR.RESULTS
Establishing AP2s Mutant Stable Cell Lines
To investigate further the effects of FHH3-associated AP2s
mutations on CaSR signaling and trafficking, HEK293 cells
stably expressing AP2s wild-type (WT; R15) or mutant
(C15, H15, and L15) proteins were established, using appro-
priate pcDNA3.1-AP2S1 constructs that also had silent muta-
tions, which rendered them resistant to AP2s-targeted small
interfering RNA (siRNA), thereby allowing study of the mutant
protein in the absence of endogenous protein. The presence of
AP2s mutant proteins or siRNA-resistant mutations did not
affect expression of endogenous AP2a, AP2b, or AP2m that
with the s subunit form the heterotetrameric AP2; general cla-
thrin-mediated endocytic functions such as transferrin uptake;
or internalization and signaling of another GPCR, the b2AR (Fig-
ure S1). These stably expressing AP2s cells were transiently
transfected with pEGFP-CaSR-WT (AP2s/CaSR-WT) cells (Fig-
ure S1). All AP2s mutant/CaSR-WT cells, when compared to
AP2s-WT/CaSR-WT cells, had a decreased sensitivity to in-
creases in Ca2+e-induced Ca
2+
i, which is mediated by Gaq/11,
with significantly higher half-maximal effective concentration
(EC50) values (Figure S2). These results, which are in agreement
with our previous results from HEK293 cells transiently express-
ing AP2smutants (Nesbit et al., 2013b), demonstrate that these
stably expressing AP2s mutant cells have impaired Gaq/11-
mediated, Ca2+e-induced Ca
2+
i release and that they are there-
fore suitable for studying the effects of FHH3-associated AP2s
mutations on CaSR signaling pathways and trafficking.
AP2s Mutations Reduce Gaq/11 Signaling
We hypothesized that Ca2+e-induced Ca
2+
i release of AP2s
mutant/CaSR-WT cells may be due to reduced calcium oscilla-
tions, and we assessed this by using single-cell microfluorimetry
with the calcium-indicating dye Fura-2 in response to increasing
concentrations (0–15 mM) of Ca2+e. CaSR-mediated Ca
2+
i oscil-
lations were observed to occur from 1 to 5 mMCa2+e, consistent
with previous reports, but mutant cells were found to have
reduced frequencies, with the AP2s-C15 and AP2s-L15 cells
requiring higher Ca2+e concentrations to begin oscillating and
AP2s-H15 cells having oscillations with irregular amplitudes
(Figures 1A and S2). Ca2+i release activates transcription factors
such as nuclear factor of activated T cells (NFAT) (Chakravarti
et al., 2012). Investigation of the effects of the FHH3-associated
AP2smutations on gene transcription, using an NFAT-response
element (RE)-containing luciferase reporter construct, revealed
that the AP2s mutant/CaSR-WT cells had significantly reduced
concentration-dependent increases in NFAT reporter activity
when compared to AP2s-WT/CaSR-WT cells (Figure 1B). Simi-
larly, assessment of the accumulation of inositol monophos-
phate (IP1), an IP3 metabolite, revealed reduced IP1 in AP2s
mutant cells compared to AP2s-WT cells (Figure S2), thereby
indicating that the PLC-IP3-DAG pathway is impaired in AP2s
mutant cells.
CaSR Gaq/11-mediated signaling also activates MAPK path-
ways (Kifor et al., 2001). Investigation of the AP2s mutant/
CaSR-WT cells using AlphaScreen analyses of ERK1/2
phosphorylation (pERK1/2) in response to elevated Ca2+eCell Reports 22, 1054–1066, January 23, 2018 1055
Figure 1. AP2s-R15 Mutations Impair Gaq/11 Signaling
(A) Number of oscillating cells measured by normalized Fura-2 ratios in response to increasing doses of Ca2+e in single AP2s/CaSR-WT HEK293 cells that stably
expressed AP2s-wild-type (WT; R15) or mutant (C15, H15, or L15) proteins and transiently expressed pEGFP-CaSR-WT (n = 36–50 cells from 9 to 10 trans-
fections). **p < 0.02 versus WT (c2 test) (Figures S1 and S2).
(B) Ca2+e-induced NFAT luciferase reporter responses in AP2s/CaSR-WT HEK293 cells (n = 8).
(C) Ca2+e-induced phosphorylation of ERK1/2 (pERK1/2) measured by AlphaScreen (n = 4). AP2s-WT/CaSR-WT cells had a dose-dependent increase in
pERK1/2, which was reduced in AP2s mutant/CaSR-WT cells within the range 2.5–5 mM Ca2+e in C15 cells and 2.5–10 mM Ca
2+
e in H15 and L15 cells.
(D) Ca2+e-induced pERK1/2 responsesmeasured by AlphaScreen in EBV-transformed lymphoblastoid cells frommembers of the FHH3 kindred in which affected
members have AP2s-C15 mutations (Figure S3). Unaffected (normal) relatives (AP2s-R15) were used as controls (n = 4).
(E) Ca2+e-induced SRE luciferase reporter responses in AP2s/CaSR-WT HEK293 cells (n = 8).
(B–E) Data are shown as mean ± SEM with *p < 0.05 and **p < 0.02 (two-way ANOVA of WT versus mutants).revealed them to have significant reductions in Ca2+e-induced
pERK1/2 responses when compared to AP2s-WT/CaSR-WT
cells (Figure 1C). Moreover, pERK1/2 responses to increases
in Ca2+e were reduced in Epstein-Barr virus (EBV)-transformed
lymphoblastoid cells from FHH3 patients with the AP2s-R15C
mutation (Figures 1D and S3), consistent with findings from
AP2s mutant/CaSR-WT cells. Expression of the AP2s subunit
genes and proteins was similar in lymphoblastoids from FHH3
patients with the AP2s-R15C and unaffected relatives, indicating
that the AP2s-R15C mutation was not affecting the stability of
the AP2 complex (Figure S3). ERK1/2 activates genes containing
serum response elements (SREs) (Pi et al., 2002). Use of a SRE
luciferase reporter revealed the AP2s mutant/CaSR-WT cells
have reduced SRE reporter activity (p < 0.02) (Figure 1E), with
the more severe effects being observed in AP2s-H15 and
AP2s-L15 mutant cells. Thus, these results demonstrate that
the FHH3-associated AP2s mutations cause a reduction in
Gaq/11 signaling via both the IP3 and the DAG pathways.
CaSR-Mediated cAMP Responses Are Altered by AP2s
Mutations
CaSR activation of the Gai/o pathway inhibits adenylate
cyclase and reduces cAMP, and we assessed the effects of1056 Cell Reports 22, 1054–1066, January 23, 2018the FHH3-associated AP2s mutations using AlphaScreen
analysis to measure Ca2+e-induced cAMP responses. Ca
2+
e
was first confirmed to reduce cAMP responses, which were
pertussis toxin (PTx) sensitive and therefore due to Gai/o
signaling, in HEK293 cells stably expressing CaSR (HEK-
CaSR) (Figure 2A). However, Gai/o inhibition only partially
affected cAMP production, and treatment with UBO-QIC, an
inhibitor of Gaq/11, revealed that the Ca
2+
e-induced reduction
in cAMP was also sensitive to Gaq/11 inhibition, thereby indi-
cating a hitherto unreported role for Gaq/11 (Figure 2B). More-
over, combined treatment of cells with both UBO-QIC and PTx
halted all Ca2+e-induced reductions in cAMP (Figure 2B) indi-
cating that G proteins other than Gaq/11 and Gai/o are unlikely
to be involved in this CaSR pathway. However, UBO-QIC has
been reported to inhibit Gbg, in addition to Gaq/11 (Gao and
Jacobson, 2016), but gallein, an inhibitor of Gbg, had no effect
on cAMP signaling (Figure 2C), thereby indicating that Gbg is
unlikely to have a role in CaSR-mediated cAMP reductions.
Increases in [Ca2+]e also led to a dose-dependent reduction
in cAMP in AP2s-WT/CaSR-WT cells, but not in AP2s
mutant/CaSR-WT cells, with cAMP in AP2s-C15/CaSR-WT
cells remaining at basal levels (Figure 2D) and with AP2s-
H15/CaSR-WT and AP2s-L15/CaSR-WT cells responding
Figure 2. AP2s-R15 Mutations Impair the Gai/o Signaling Pathway
Ca2+e-induced cAMP inhibition was measured by AlphaScreen.
(A) Effect of ethanol-diluent (vehicle, veh) or pertussis toxin (PTx) on Ca2+e-induced cAMP inhibition in HEK-CaSR-WT cells. PTx inhibits Gai/o-mediated, Ca
2+
e-
induced cAMP reductions (n = 4).
(B) Effect of veh, PTx, the Gaq/11 inhibitor UBO-QIC (UBO), or combined PTx andUBO treatment on Ca
2+
e-induced cAMP inhibition in HEK-CaSR-WT cells (n = 4).
(C) Effect of DMSO (vehicle, veh) or the Gbg inhibitor gallein on Ca2+e-induced cAMP inhibition in HEK-CaSR-WT cells. Gallein did not significantly alter Ca
2+
e-
induced cAMP responses when compared to vehicle (n = 4).
(D–F) Ca2+e-induced cAMP inhibition in AP2s-WT/CaSR-WT and AP2smutant/CaSR-WT HEK293 cells. AP2smutant cells—(D) C15, (E) H15, and (F) L15—had
impaired responses when compared to WT (AP2s-R15) cells (n = 8–12).
(G) Ca2+e-induced cAMP inhibition in EBV-transformed lymphoblastoid cells from FHH3 patients, with AP2s-C15 mutation, and unaffected (normal) relatives
(Figure S3).
Data are shown as mean ± SEM with *p < 0.05 and **p < 0.02 (two-way ANOVA comparing WT versus mutant in AP2s HEK293 cells and normal versus FHH3
affected in lymphoblastoid cells). (B) shows vehicle versus PTx (black asterisk), UBO (dollar signs), and combined PTx and UBO (gray asterisks).with reductions in cAMP (Figures 2E and 2F). Moreover, lym-
phoblastoid cells from FHH3 patients with the AP2s-R15C mu-
tation, when compared to those from normal relatives, did not
have Ca2+e-induced cAMP responses (Figure 2G), consistent
with findings from the AP2s-C15/CaSR-WT cells. Thus, the
FHH3-associated AP2s mutants reduce Gai/o- and Gaq/11-
mediated effects on cAMP responses.
AP2sMutations Reduce Membrane Ruffling
CaSR has been reported to induce cytoskeletal changes such as
membrane ruffling by both Gaq/11 and Ga12/13 signaling (Bou-
schet et al., 2007;Huang et al., 2004; Pi et al., 2002).We therefore
investigated the effects of FHH3-associated AP2s mutants onmembrane ruffling, using AP2smutant/CaSR-WT cells and phal-
loidin-594 as an actin marker. Elevations of Ca2+e increased
membrane ruffling in AP2s-WT and mutant cells, although
AP2s mutant cells had significantly reduced membrane ruffling
compared toWT cells (p < 0.02) (Figures 3A andS4). Assessment
of membrane ruffling-induced gene transcription (Tojkander
et al., 2012) using a serum response factor (SRF)-RE reporter
construct revealed AP2s mutant cells to have significantly
reduced SRF activity compared to AP2s-WT cells (Figure 3B).
Further investigation of SRF reporter assays in HEK293 cells
transiently expressing CaSR but depleted of Gaq/11, Ga12/13, or
Gaq/11/12/13 revealed SRF activity to be abolished in Gaq/11 and
Gaq/11/12/13 knockout cells but to be significantly higher inCell Reports 22, 1054–1066, January 23, 2018 1057
Figure 3. AP2s-R15 Mutations Impair Membrane Ruffling via Reduction in Gaq/11 Signaling
(A) Percentage of AP2s/CaSR-WT cells with membrane ruffling (Figure S4) at each Ca2+e concentration measured. Numbers (n) of cells—AP2s-WT (R15) or
mutant (C15, H15, or L15)—and coverslips are indicated. **p < 0.02 (c2 test).
(B) Ca2+e-induced SRF luciferase reporter activity (n = 8). Responses were reduced in AP2s mutant cells.
(C) Ca2+e-induced SRF luciferase reporter activity in native HEK293 cells or CRISPR-Cas gene-edited HEK293 knockout cells of Gaq/11, Ga12/13, or Gaq/11/12/13
transfected with pEGFP-CaSR-WT. () denotes genes deleted. SRF reporter activity was abolished in cells depleted of Gaq/11 and Gaq/11/12/13 but elevated in
cells depleted of Ga12/13.
Data are shown as mean ± SEM (n = 8) with *p < 0.05 and *p < 0.02 (two-way ANOVA of WT, or native, versus mutant).Ga12/13 knockout cells than in native cells (Figure 3C). Moreover,
quantification of membrane ruffling in Ga12/13 knockout cells and
native HEK293 cells transiently expressing CaSR showed them
to have similar levels of ruffling (Figure S4), thereby indicating
the existence of Ga12/13-independent ruffling pathways. Overall,
these results indicate that Ca2+e-induced membrane ruffling in
HEK293 expressing CaSR is mediated by Gaq/11 signaling and
that FHH3-associated AP2s mutations, which impair Gaq/11
signaling, reduce membrane ruffling.
AP2s Mutations Impair CaSR Internalization and
Differentially Affect CaSR Cell-Surface Expression,
which Both Require Gaq/11
FHH3-associated AP2s mutations have been reported to result
in increased CaSR cell-surface expression, which represents
the net balance between its PM insertion by ADIS and removal
by endocytosis (Grant et al., 2011). We therefore simultaneously
measured the effects of the FHH3-associated AP2s mutations
on ADIS and endocytosis by transfecting AP2s-WT and AP2s
mutant cells with a plasmid construct containing full-length
CaSR, with an N-terminal modification that in tandem comprised
a minimal a-bungarotoxin (BTx)-binding site to monitor endocy-
tosis and superecliptic pHluorin (SEP) to monitor total cell-sur-
face CaSR, referred to as BSEP-CaSR (Figure 4A) (Grant et al.,
2011). Total internal reflection fluorescence (TIRF) microscopy
was used to assess CaSR cell-surface expression under basal
(0.1 mM Ca2+e) conditions or following exposure to 5 or 10 mM
Ca2+e. Immediately before TIRF microscopy continuous record-
ings, cells were exposed to BTxwith a fluorescent tag (BTx-594).
AP2s-WT and mutant cells expressed CaSR at the cell surface
(Figures 4B and 4C), and both 5 and 10 mM Ca2+e induced ele-
vations in SEP fluorescence and reductions in BTx-594. These
were greater at 10 mM Ca2+e, which was used for subsequent
imaging experiments (Figures 4B, 4C, and S5). Thus, elevations
in Ca2+e increased CaSR PM insertion (Figures 4B and 4C), and
returning Ca2+e to basal conditions induced a reduction in cell
surface CaSR, observed by a decline in SEP fluorescence (Fig-
ure 4C). Maximal SEP fluorescence in AP2s-C15 cells was1058 Cell Reports 22, 1054–1066, January 23, 2018similar to WT, but AP2smutant L15 cells had reduced SEP fluo-
rescence and H15 cells had significantly higher CaSR PM
expression (p < 0.01, F test) (Figures 4B and 4C). All AP2smutant
cells had slower declines in BTx-594 PM fluorescence when
compared to AP2s-WT cells, thereby indicating delayed
internalization (Figure 4D). The time to internalize 75% of the
BTx-594 at the PM was significantly increased from 268 s in
AP2s-WT to 346, 741, and 350 s in AP2s-C15, AP2s-H15, and
AP2s-L15 mutant cells, respectively (p < 0.05 to p < 0.02) (Fig-
ure 4E). This was greatest in the AP2s-H15 cells, which may
partly account for the very high CaSR PM expression in
these cells (Figure 4C). Moreover, TIRF microscopy analysis of
Gaq/11 knockout cells transfected with BSEP-CaSR showed
that the Ca2+e-induced increase in SEP fluorescence (i.e.,
increased CaSR PM expression via ADIS) was lost and that
CaSR internalization measured by BTx-594 fluorescence was
severely impaired (Figures 4F and 4G). These findings indicate
that Gaq/11 signaling is required for ADIS responses and that
CaSR endocytosis requires a signal within the Gaq/11 pathway
for its maintenance.
CaSR Delayed Internalization Is due to Prolonged CaSR-
Clathrin Colocalization in AP2s Mutant Cells
AP2s mutants impair but do not abolish CaSR internalization
(Figure 4), indicating that AP2 and clathrin are still recruited to
the forming endocytic pit but that CaSR internalization occurs
at a slower rate. We therefore predicted that the duration of
colocalization between CaSR and clathrin may be prolonged, re-
flecting this slower internalization rate. We investigated this by
transfecting AP2s mutant and AP2s-WT cells with BSEP-
CaSR and dsRed-Clathrin and analyzed colocalization by TIRF
microscopy. Clathrin fluorescence increased in the AP2s-WT
and AP2s mutant cells during the TIRF microscopy recording,
indicating that clathrin is recruited to the PM, although the in-
crease in clathrin recruitment to the PM was significantly greater
in AP2s-WT than in AP2s mutant cells (p < 0.02) (Figure 5A).
Vesicles containing both clathrin and CaSR were analyzed for
motility, because higher motility is associated with increased
Figure 4. AP2s-R15 Mutations Impair CaSR Internalization
TIRF microscopy analyses in AP2s-WT (R15) or mutant (C15, H15, or L15) HEK293 cells transfected with BSEP-CaSR.
(A) Schematic diagram of BSEP-CaSR. BSEP-CaSR encodes CaSR with an N-terminal modification of a minimal bungarotoxin (BTx) binding site, to which
BTx-594 binds to measure endocytosis, and superecliptic pHluorin (SEP), which maximally fluoresces at neutral pH and measures total cell surface CaSR.
(B) TIRF microscopy images of SEP and BTx-594 fluorescence. Blue arrows indicate addition of 10 mM, and red arrows the return to 0.1 mM Ca2+e.
(C andD) Quantification of fluorescence in eachmovie frame for (C) SEP and (D) BTx-594 images. [Ca2+]e is shown above. Data are normalized to the fluorescence
in the first frame of each movie (set at 100%). Data are shown as mean + SEM.
(E) Time taken to reduce BTx-594 expression by 25%, 50%, and 75%.
(F and G) TIRF microscopy analyses in native HEK293 cells or CRISPR-Cas gene-edited HEK293 cells of Gaq/11 transfected with BSEP-CaSR. Quantification of
fluorescence in each movie frame for (F) SEP and (G) BTx-594 images. [Ca2+]e is shown above. () denotes genes deleted. Cells depleted of Gaq/11 had impaired
ADIS and endocytosis. Data are shown as mean + SEM with *p < 0.05 and **p < 0.02 for comparison to WT (two-way ANOVA).likelihood of viable endocytic events (Rappoport and Simon,
2003). Vesicles that had both CaSR and clathrin were highly
motile in AP2s-WT cells, which had a greater proportion of
highly motile CaSR-clathrin-containing vesicles than AP2s-H15
and AP2s-L15 cells; instead, these AP2s mutant cells had a
significantly greater number of non-motile CaSR-clathrin-con-
taining vesicles (p < 0.02) (Figures 5B and 5C). The reduced
motility of the CaSR-clathrin-containing positive vesicles in
AP2s mutant cells would delay vesicle internalization and
thereby likely prolong the colocalization of CaSR and clathrin in
clathrin-coated pits. Assessment of the duration of CaSR-cla-
thrin colocalization in individual vesicles revealed that all AP2s
mutant cells, when compared to AP2s-WT cells, had prolonged
CaSR-clathrin associations (Figure 5D). However, motile vesi-
cles in AP2s-WT and AP2s-C15 cells had a significantly shorterduration of colocalization when compared to non-motile vesi-
cles, indicating that these motile vesicles are likely resulting in
endocytic events, although there was no significant difference
between motile and non-motile vesicles in H15 and L15 cells
(Figure 5D). These results indicate that CaSR internalization is
impaired in AP2s mutant cells at distinct stages of endocytosis
by prolonged residency time at clathrin-coated pits and/or
vesicles.
CaSR Is Able to Induce Sustained Signaling from a
Cytoplasmic Location
The FHH3-associated AP2s mutations resulted in impaired
CaSR-induced signaling (Figures 1, 2, and 3), despite increased
CaSR cell-surface expression (Figure 4) due to delayed internal-
ization. This led us to hypothesize that CaSR signaling mayCell Reports 22, 1054–1066, January 23, 2018 1059
Figure 5. Impairments in CaSR Internaliza-
tion Are due to Prolonged CaSR-Clathrin Co-
localization
TIRF microscopy analyses of colocalized CaSR
(BSEP-CaSR) and Clathrin (dsRed-Clathrin) per-
formed in AP2s-WT (R15) or mutant (C15, H15, or
L15) cells.
(A) Quantification of clathrin fluorescence with
changes in [Ca2+]e (shown above). Data are
normalized to the fluorescence in the first frame
of each movie (set at 100%). Data shown as
mean ± SEM.
(B) Images of CaSR and clathrin expression in single
vesicles (yellow arrow).
(C and D) Proportion of motile (M) versus non-motile
(NM) CaSR and clathrin-containing vesicles (C),
and duration of colocalization between CaSR and
Clathrin in individual (motile, M, filled box, and non-
motile, NM, open box) vesicles (D).
Data from 95 to 200 vesicles (n = 14–16 recordings)
are expressed as mean ± SEM with *p < 0.05 and
**p < 0.02 (two-way ANOVA) illustrated by black and
red asterisks for WT motile versus mutant motile
vesicles and C15 motile versus non-motile vesicles,
respectively.require, or be enhanced, by receptor internalization that would
contribute to sustained (i.e., non-canonical) signaling. To test
this hypothesis, we treated HEK293-CaSR cells with the dyna-
min-blocking agent Dyngo, which would abolish endocytosis
and prevent endosomal signaling, and assessed their MAPK
signaling responses by measurement of pERK1/2 to a 5 min
pulse of 5 mM Ca2+e. pERK1/2 accumulated in Dyngo-treated
and control DMSO-treated cells from 2 to 5 min and then rapidly
decreased in Dyngo-treated cells, but not DMSO-treated cells;
in the latter, pERK1/2 remained significantly increased at
30 min, indicating a potential sustained signaling response (Fig-
ures 6A, 6B, and S5). Loss of this sustained response in Dyngo-
treated cells was not due to increased apoptosis, decreased
proliferation, or inhibition of CaSR protein synthesis, because
the sustained rise in pERK1/2 was not blocked by tunicamycin
(Figure S5). The effects of this sustained pERK1/2 signaling on
transcription were investigated by SRE reporter activity in
HEK-CaSR cells treated with constant or 5min pulsed elevations
in Ca2+e. Constant treatment with 5 mM Ca
2+
e, when compared
to 0.1 mM Ca2+e, resulted in rapid increases in SRE reporter ac-
tivity that peaked between 4 and 6 hr, after which they rapidly
reduced (Figure 6C). However, pulsed elevations with 5
and 7.5 mM, followed by incubation with basal 0.1 mM Ca2+e
for 0–12 hr, resulted in a peaked response between 4 and 6 hr
that was followed by a second peaked response at 9 hr, consis-
tent with a sustained signaling response (Figure 6D). Treatment1060 Cell Reports 22, 1054–1066, January 23, 2018with Dyngo abolished the second peaked
response in HEK-CaSR cells given a
5 min pulse of 5 mM Ca2+e (Figure 6E),
thereby indicating that the sustained
signaling response was likely originating
from endosomes. An endosomal origin of
this sustained response was further inves-tigated by measuring pERK1/2 responses at 5 and 30 min
in HEK-CaSR cells overexpressing the early endosome guano-
sine triphosphatase (GTPase) Rab5; a dominant-negative (DN)
S34N guanosine diphosphate (GDP)-bound form, which delays
endocytosis by retaining cargo in clathrin-coated pits (CCPs);
and a constitutively active (CA) Q79L form, which enhances en-
docytic processes (Galperin and Sorkin, 2003; Stenmark et al.,
1994). Rab5 was shown to be overexpressed by these con-
structs, and confocal microscopy showed that FLAG-CaSR-
WT internalized over time in response to 5 mM Ca2+e
and partially colocalized with Rab5-WT-containing structures
(Figure S6). Expression of Rab5-WT did not affect CaSR inter-
nalization, while the Rab5-DN protein delayed and reduced
receptor internalization (Figure S6). In addition, HEK-CaSR
cells expressing Rab5-CA when compared to Rab5-WT had
enhanced pERK1/2 signals at 5 and 30 min, while Rab5-DN
had reduced pERK1/2 signals at 30 min (Figures 6F and 6G).
Furthermore, investigation of SRE reporter responses showed
that the Rab5-DN reduced overall CaSR-driven SRE reporter ac-
tivity (Figure 6H), which was due to loss of the sustained signal at
9 hr rather than reduction in immediate signaling (Figure 6I).
MAPK signaling can be activated via Gaq/11 and Gai/o pathways
(Figure S5) (Holstein et al., 2004). To assess the contribution of
Gaq/11 and Gai/o signaling to sustained endosomal signaling,
we measured SRE reporter activity in HEK-CaSR cells treated
with UBO-QIC, an inhibitor of Gaq/11, or PTx, a specific inhibitor
Figure 6. Second Signal of CaSR Is from the Rab5-Endosomal Internalization Pathway
(A) Effects of dynamin inhibitor Dyngo onMAPK signaling by western blot analyses of pERK1/2 responses in HEK-CaSR cells treated with Dyngo (+) or DMSO (),
given a 5 min pulse of 5 mM Ca2+e, and then incubated in 0.1 mM Ca
2+
e.
(B) Densitometry analysis showing data from blots (n = 8). Black and blue asterisks indicate p values of response versus response at 0 min for DMSO and Dyngo
treated, respectively; green asterisks indicate DMSO versus Dyngo responses.
(C) SRE luciferase reporter responses to treatment of either 0.1 or 5 mM Ca2+e over 12 hr in HEK-CaSR cells. Asterisks indicate p values of response versus
response to 0.1 mM (n = 4).
(D) SRE luciferase reporter activity in response to 5 min pulses of 0–10 mM Ca2+e in HEK-CaSR cells. Asterisks indicate p values of 0.1 mM responses versus
2.5 mM (red), 5 mM (green), 7.5 mM (blue), and 10 mM (yellow) (two-way ANOVA) (n = 4). Both initial and sustained peaks were enhanced by increasing con-
centrations of Ca2+e, which plateaued at 7.5 mM. Subsequent experiments were performed at Ca
2+
e = 5 mM.
(E) SRE luciferase reporter responses to a 5min pulse of 0.1 or 5 mMCa2+e with DMSO () or Dyngo (+) in HEK-CaSR cells. DMSO (blue)-treated cells and Dyngo
(red)-treated cells had a peak at 4 hr, while the second peak at 9 hr was abolished by treatment with Dyngo. Asterisks indicate p values of 0.1 mM Ca2+e versus
DMSO (blue) or Dyngo (red) and DMSO versus Dyngo (green) (two-way ANOVA).
(F) Western blot analysis of pERK1/2 responses in HEK-CaSR cells exposed for 5 or 30 min to 5 mM Ca2+e. Cells were transiently transfected with the Rab5 WT
(S34/Q79) or the constitutively active (CA; L79) or dominant-negative (DN; N34) Rab5 mutants.
(G) Densitometric analyses of pERK1/2 in western blots (n = 4). Asterisks indicate p values of mutants compared to WT responses at each time point (two-way
ANOVA). Rab5-CA had higher expression of pERK1/2 after 5 and 30 min of treatment, while Rab5-DN had lower pERK1/2 responses after 30 min.
(H) SRE luciferase reporter responses to treatment of 0.1 or 5 mM Ca2+e over 12 hr in HEK-CaSR cells transiently transfected with Rab5-WT or Rab5-DN mutant
(n = 8).
(I) SRE luciferase reporter response to 5 min pulses of 0.1 or 5 mM Ca2+e in HEK-CaSR cells transiently transfected with Rab5-WT or Rab5-DN mutant (n = 8).
(J) SRE luciferase reporter responses to treatment of 0.1 or 5 mM Ca2+e over 12 hr in HEK-CaSR cells treated with DMSO or the Gaq/11 inhibitor UBO-QIC (UBO)
(n = 4).
(K) SRE luciferase reporter response to 5 min pulses of 0.1 or 5 mM Ca2+e in HEK-CaSR cells treated with DMSO or UBO (n = 4).
(L) SRE luciferase reporter responses to treatment of 0.1 or 5 mM Ca2+e over 12 hr in HEK-CaSR cells treated with vehicle (Veh) or PTx, a Gai/o inhibitor (n = 8).
(M) SRE luciferase reporter response to 5 min pulses of 0.1 or 5 mM Ca2+e in HEK-CaSR cells treated with Veh or PTx (n = 8).
Rab5-DN, UBO, and PTx all reduced constant Ca2+e responses. In (H)–(M), asterisks show basal 0.1 mMCa
2+
e responses versus 5mMCa
2+
e responses in Rab5-
WT-, DMSO-, or Veh-treated cells (black); basal 0.1 mM Ca2+e responses versus 5 mM Ca
2+
e responses in Rab5-DN-, UBO-, or PTx-treated cells (blue); and
Rab5-WT versus Rab5-DN, DMSO versus UBO, or Veh versus PTx (green) (two-way ANOVA). **p < 0.02, *p < 0.05. Rab5-DN and UBO reduced the sustained
MAPK signal, while PTx had no effect on the sustained signal.
Cell Reports 22, 1054–1066, January 23, 2018 1061
of Gai/o (Figures 6J–6M). In the presence of constant 5 mM
Ca2+e, SRE reporter activity was reduced in UBO-QIC- and
PTx-treated cells compared to vehicle-treated cells (Figures 6J
and 6L). However, in cells treated with a 5 min pulse of 5 mM
Ca2+e, UBO-QIC and PTx similarly impaired the early SRE
response (Figures 6K and 6M), but only UBO-QIC reduced the
sustained signal, which was not affected by PTx (Figures 6K
and 6M). Thus, these findings indicate that Gai/o does not
contribute to the sustained MAPK response from endosomes,
which solely involves Gaq/11. The presence of Gaq/11 signaling
pathway components in endosomes containing internalized
CaSR was confirmed by using HEK293 cells transfected with
FLAG-tagged CaSR and either Gaq-Venus or a known GFP-
tagged biosensor of PIP2 (the lipid catalyzed by PLC), which con-
tains the pleckstrin homology domain of PLC-delta (PH-PLC)
(Stauffer et al., 1998). Before addition of 5 mMCa2+e, colocaliza-
tion of CaSRwith either Gaq or PH-PLCwas observed only at the
PM; however, following treatment with 5 mM Ca2+e for 10 and
30 min, a subpopulation of CaSR-containing endosomes that
colocalized with Gaq or PH-PLC was detected, thereby indi-
cating that internalized CaSR endosomes have Gaq/11 signaling
components (Pearson’s correlation coefficients = 0.658 ± 0.027
for CaSR/Gaq and 0.652 ± 0.024 for CaSR/PH-PLC at 10 min
and 0.693 ± 0.049 for CaSR/Gaq and 0.743 ± 0.059 for CaSR/
PH-PLC at 30 min; n = 8–15) (Figure S6). To further assess the
role of PLC in sustained signaling, we measured the effect of in-
hibitors of the PLC-DAG-IP3 pathway (Figure S7) on pERK1/2
responses. HEK-CaSR cells were pulsed with 5 mM Ca2+e and
then treated with DMSO or with U73122, GF-109203X (GFX),
or 2-aminoethoxydiphenyl borate (2-APB), which inhibits PLC,
PKC, or the IP3 receptor (IP3R), respectively (Figure S7).
pERK1/2 accumulated in all cells from 2 to 5 min, and sustained
responses were observed in DMSO-treated cells but were signif-
icantly reduced in U73122, GFX, and 2-APB-treated cells (Fig-
ure S7), thereby confirming the requirement of this Gaq/11
effector for sustained signaling. Finally, we assessed the effects
of the scaffold proteins barrestin-1 and barrestin-2, which are
important for endosomal signaling of GPCRs such as V2R and
PTH1R (Feinstein et al., 2013; Wehbi et al., 2013), on the sus-
tained signaling in HEK-CaSR cells and HEK293 cells that had
deletions of barrestin-1 and barrestin-2, which were generated
by CRISPR-Cas and stably overexpressed CaSR (Figure S7).
The pERK1/2 and SRE reporter responses to a 5 min pulse of
Ca2+e in these cells lacking barrestin-1 and barrestin-2 showed
no difference in responses when compared to WT cells, thereby
indicating that barrestin-1 and barrestin-2 are not required for the
CaSR sustained signal (Figure S7).
AP2s-R15 Mutations Impair Sustained Endosomal
Signaling
FHH3-associated AP2s mutations impair CaSR signaling and
internalization. We hypothesized that these AP2s mutations
were inhibiting sustained endosomal CaSR signaling and tested
this by measuring the non-canonical SRE reporter responses in
AP2s-WT/CaSR-WT and AP2s mutant/CaSR-WT cells treated
with Dyngo, or overexpressing DN Rab5 (Figures 7A and S6).
In the presence of constant 5mMCa2+e, SRE reporter responses
were significantly higher in AP2s-WT than in mutant cells, with1062 Cell Reports 22, 1054–1066, January 23, 2018peak expression occurring between 3 and 5 hr, in all cell lines
(Figure 7A). Measurements of SRE reporter activity following a
5 min pulse of 5 mM Ca2+e showed that the second Dyngo-sen-
sitive peak was significantly reduced in C15 cells and abolished
in H15 and L15 cells compared to WT cells (Figure 7B), thereby
revealing that the FHH3-associated AP2s mutations impaired
early and sustained endosomal signaling.Moreover, the reduced
sustained signaling in AP2s-C15 cells was abolished by Rab5-
DN, further demonstrating the endosomal origin of the sustained
signaling (Figure S6). In summary, our results show that CaSR
can induce sustained MAPK signaling from Rab5 endosomes
and that FHH3-associated AP2s mutations (C15, H15, and
L15) impair Ca2+i signaling, MAPK responses, cAMP reductions,
and membrane ruffling and impair or abolish sustained signaling
from the endosome.
DISCUSSION
Our study, which demonstrates that CaSR sustained signaling
can occur by a non-canonical endosomal pathway, in addition
to the established canonical PM pathway (Figure 7C), provides
an explanation for the observed reduction in CaSR signaling
that is paradoxically associated with increased CaSR PM
expression because of FHH3-associated AP2s mutations (Fig-
ures 1, 2, 3, and 4) (Nesbit et al., 2013b). Thus, in normal cells,
total CaSR signaling comprises the output from the PM immedi-
ate and endosomal sustained pathways (Figure 7C); however, in
cells with FHH3-associated AP2smutations, which impair CaSR
internalization (Figure 4), the contribution from the endosomal
pathway is lost or markedly reduced, with the remaining CaSR
signaling occurring from the PM pathway (Figure 7C). Thus,
CaSR endosomal signaling, which is sensitive to the dynamin-
blocking agent Dyngo (Figure 6) and to DN mutants of the early
endosomal protein Rab5 (Figure 6), occurs via Gaq/11 (Figures
5 and 6). Gaq/11 mediates alterations in Ca
2+ (Figure 1), cAMP
(Figure 2), membrane ruffling (Figure 2), and MAPK responses
(Figure 1), all of which are impaired in cells expressing FHH3-
associated mutations of AP2s (Figures 1 and 2) that forms
part of the heterotetrameric AP2 that plays a critical role in
clathrin-mediated endocytosis. This CaSR sustained signaling
is also not affected by tunicamycin (Figure S5), indicating a
lack of requirement for newly synthesized CaSRs (Grant et al.,
2011).
The three FHH3-associated AP2s-R15 mutants, which all
affected CaSR internalization—but not uptake of other clathrin-
mediated endocytic cargos, such as transferrin or another
GPCR, the b2AR (Figure S1)—had different effects on CaSR
endocytosis and consequently different effects on signaling.
Critically, these AP2 mutations unveiled that Gaq/11 signaling
was more sensitive to alterations in CaSR endocytosis than
the Gai/o pathway. Thus, the AP2s-C15 mutant delayed CaSR
internalization at the CCP (Dyngo sensitive) stage, whereas
the AP2s-H15 and AP2s-L15 mutants inhibited CaSR internali-
zation at the clathrin-coated vesicle (CCV) (Rab5-DN sensitive)
stage. These milder effects of the AP2s-C15 mutant on CaSR
internalization still reduced Gaq/11 signaling, thereby indicating
a possible threshold requirement for receptor occupancy within
endosomes for activation of this G-protein pathway. In addition,
Figure 7. AP2s-R15 Mutations Impair Sus-
tained Signaling from Endosomes
Studies of sustained signaling using SRE luciferase
reporter assays in AP2s-WT/CaSR-WT and AP2s
mutant/CaSR-WT HEK293 cells.
(A) SRE luciferase reporter responses to constant
treatment of 0.1 or 5 mM Ca2+e. Asterisks indicate
p values for WT versus mutant responses (green)
(n = 10–12). Statistical comparisons between 0.1
and 5 mM in the same cell type are not shown but
were significantly greater for 5 mM in all cells be-
tween hours 2 and 11 (p < 0.05). Responses to 5mM
Ca2+e were significantly greater in AP2s-WT (R15)
cells compared to AP2smutant (C15, H15, and L15)
cells. Data are shown as mean + SEMwith *p < 0.05,
**p < 0.02 (two-way ANOVA).
(B) SRE luciferase reporter response to 5 min pulses
of 5 mM Ca2+e treated with DMSO (blue) or Dyngo
(red) in AP2s-WT or AP2s mutant cells (n = 10–12).
Blue and red asterisks indicate WT versus mutant
cells treated with DMSO and with Dyngo, respec-
tively, and green asterisks and dollar signs indicate
WT DMSO versus WT Dyngo and mutant DMSO
versus mutant Dyngo, respectively. Data are shown
as mean + SEM with *p < 0.05, **p < 0.02 or $$p <
0.02 (two-way ANOVA).
(C) Summary of effects of AP2s-R15 mutations on
CaSR signaling pathways. CaSR is able to signal
from the PM (red), using the Gaq/11 and Gai/o path-
ways to enhance MAPK signaling and to reduce
cAMP, and increase membrane ruffling and Ca2+i
release, using Gaq/11. Following activation, CaSR is
clustered into CCPs, before vesicle scission and
internalization in clathrin-coated vesicles, and then
into endosomes. Our results show that CaSR can
induce sustained MAPK signaling (blue) from Rab5
endosomes and that FHH3-associated AP2s mu-
tations (C15, H15, and L15) impair all immediate
signaling pathways (red) and impair or abolish sus-
tained Gaq/11 signaling from the endosome, with
responses of MAPK shown as a solid blue line
(Figures 6 and 7) and other likely responses shown
as a broken blue line and in parentheses. Pit invag-
ination can be blocked by Dyngo, and maturation to
Rab5-positive vesicles can be blocked by DN Rab5
mutant.the AP2s-C15 mutant, but not AP2s-L15 or AP2s-H15, signifi-
cantly affected Gai/o signaling at high [Ca
2+]e, i.e., 10 mM (Fig-
ure 2), thereby suggesting that CaSR-mediated Gai/o signaling
at high [Ca2+]e is regulated at the CCPs, as opposed to Rab5
endosomes. Furthermore, Gai/o, which can enhance MAPK
signaling (Kifor et al., 2001), does not contribute to the sustained
signal (Figures 6L and 6M), demonstrating the stronger require-
ment of receptor endocytosis for Gaq/11 signaling. In contrast,
the AP2s-L15 mutant, which had impaired CaSR internalization
and abolished Gaq/11-mediated sustained MAPK signaling, re-
sulting in the most severely reduced Gaq/11 signaling, had mark-
edly reduced ADIS responses (Figure 4). These findings indicate
not only that endosomal Gaq/11 signaling is critical for ADIS (Fig-
ures 4, 5, and 6) but also that there is a link between CaSR traf-
ficking and signaling, thereby providing support for the proposed
communication between endosomal compartments and the
secretory machinery that links GPCR trafficking to maintainmembrane receptor functionality (Clague and Urbe´, 2001).
Finally, the regulation of CaSR sustained signaling via its local
environment within the endosome has yet to be established.
Studies of the effect of different ligands, pH, receptor density,
and tissue-specific differences that have previously been recog-
nized for the CaSR (Conigrave and Ward, 2013; Quinn et al.,
2004) require further investigation within the sustained signal
context.
Our results reveal that the CaSR, a class C GPCR, induces
sustained endosomal signaling (Figures 5, 6, and 7). This has
similarities to reports for class A GPCRs, such as b2AR and
LHR, which do not require barrestin for endosomal and/or
MAPK sustained signals (Irannejad et al., 2013; Jean-Alphonse
et al., 2014). Moreover, GPCRs that use non-canonical signals
often do so to facilitate biased agonism. This is illustrated by
the class A GPCR V2R, which elicits sustained endosomal sig-
nals with vasopressin but rapid signals with oxytocin (FeinsteinCell Reports 22, 1054–1066, January 23, 2018 1063
et al., 2013), and the class B PTH1R, which has sustained signals
for PTH but rapid signals for PTH-related peptide (Ferrandon
et al., 2009). Such spatial control of GPCR signaling has
emerged as an important mechanism by which cells translate
complex information into distinct cellular responses using a finite
number of signal proteins. This is particularly the case for the
CaSR, which has wide-ranging functions in diverse cell types,
is able to couple to multiple G proteins, and responds to a variety
of ligands. Thus, the ability to use immediate and sustained
signaling pathways could account for some tissue- and cell-spe-
cific functions of the CaSR. For example, an immediate signaling
pathway would likely facilitate the CaSR to rapidly respond to
changes in [Ca2+]e to restore calcium homeostasis by parathy-
roid and renal cells. In contrast, the role of CaSR in fetal develop-
ment and bone mineralization (Goltzman and Hendy, 2015;
Riccardi et al., 2013), which may require long-acting signals,
may be facilitated by a sustained signaling pathway, providing
a mechanism for the functional diversity of the CaSR.
In conclusion, our studies have demonstrated that the CaSR, a
class CGPCR,mediates a sustained signal from an internal loca-
tion that is likely to be the endosomes. In addition, our systematic
characterization of CaSR signaling by such non-canonical, inter-
nalization-dependent (e.g., endosomal) pathways provides a
paradigm for understanding how pleiotropic signaling pathways
activated by a single GPCR can be resolved via spatially directed
G-protein selectivity.
EXPERIMENTAL PROCEDURES
Detailed methods and information on constructs, oligonucleotides, and anti-
bodies can be found in the Supplemental Experimental Procedures.
Ethics Statement
Informed consent was obtained from individuals using protocols approved by
local and national ethics committees, London, UK (MREC/02/2/93).
Cell Culture
HEK-CaSR have been described (Nesbit et al., 2013b). HEK293 cells stably
expressing AP2s WT or mutant proteins were generated using a pcDNA3.1
construct (Invitrogen) containing full-length AP2s cDNA with silent mutations
to protect against AP2s siRNA (Santa Cruz Biotechnology). Clonal cells
were generated as described (Nesbit et al., 2013b), and cells with deletion of
Gaq, Ga11, Ga12, Ga13, barrestin-1, and barrestin-2 by CRISPR-Cas have
been described (Devost et al., 2017). Epstein-Barr virus-transformed lympho-
blastoid cells were generated frommembers of the FHH3 kindred as described
(Parkinson and Thakker, 1992). Transfections were performed with Lipofect-
amine 2000 (Invitrogen). Mutations within constructs were introduced by
site-directed mutagenesis using Quikchange Lightning XL or Multi kits (Agilent
Technologies) and confirmed by sequencing as described (Newey et al., 2013).
Western Blot
For sustained signaling studies, cells were stimulated with 5 mM CaCl2 for
5 min, followed by incubation in 0 mM CaCl2 for 0–60 min. For studies with
30 mM Dyngo-4a (Abcam) (Jean-Alphonse et al., 2014), cells were pre-incu-
bated for 30 min. For studies with 5 mM U73122 (Sigma), 1 mM GFX (Sigma),
100 mM 2-APB (Sigma), or 5 mg/mL tunicamycin (Sigma), compounds were
added to the media and cells were incubated after calcium stimulation. For
studies of Rab5 contribution to sustained signaling, 100 ng/mL mCh-Rab5-
WT (Addgene plasmid 49201), mCh-Rab5 dominant negative (DN; S34N) or
mCh-Rab5 CA (Q79L), were transfected 48 hr before western blot analysis.
Western blots for pERK1/2 were then performed as described (Gorvin et al.,
2017).1064 Cell Reports 22, 1054–1066, January 23, 2018Functional Assays
Transferrin assays were performed as described (Gorvin et al., 2013). IP1
assays were performed according to manufacturer’s instructions. For
pERK1/2 AlphaScreen assays, cells were transfected with pEGFP-CaSR
and treated with 0–10 mM CaCl2 for 5 min. For cAMP assays, cells were
pre-treated with forskolin for 30 min. For inhibitor studies, cells were pre-
treated with 300 ng/mL PTx or vehicle (ethanol) for 6 hr, 1 mM UBO-QIC or
vehicle (DMSO) for 2 hr, or 15 mM gallein or vehicle (DMSO) for 15 min (Grant
et al., 2011). AlphaScreen assays were performed as previously described
(Gorvin et al., 2017). Apoptosis and proliferation were assessed using Cas-
pase-Glo 3/7 and CellTiter Blue kits, respectively (Promega). For luciferase re-
porter assays, cells were transfected with pEGFP-CaSR, a reporter construct
(pGL4-NFAT, pGL4-SRE, or pGL4-SRF), and a renilla construct (pRL) as
described (Gorvin et al., 2017). Cells were treated with 0–10 mM CaCl2 for
4 hr. For sustained signaling studies, HEK-CaSR cells were transfected with
luciferase construct and pRL and given one of four treatments: (1) 0.1 mM
CaCl2, (2) 5 mM CaCl2 for the whole experiment (constant), (3) 5 min pulse
of 5 mMCaCl2 followed by 0.1 mM CaCl2 with vehicle (DMSO) for the duration
of the experiment, or (4) 5 min pulse of 5 mM CaCl2 followed by 0.1 mM CaCl2
with 30 mM Dyngo-4a for the duration of the experiment. Cells were pre-incu-
bated with 1 mM UBO-QIC or DMSO for 2 hr or 10 mM forskolin (MP Biomed-
icals) and 300 ng/mL PTx (Sigma) or vehicle (ethanol diluent) for 6 hr (Avlani
et al., 2013). Luciferase assays and Caspase-Glo 3/7 were measured on a Ver-
itas luminometer (Promega), and CellTiter Blue was measured on a CytoFluor
microplate reader (PerSeptive Biosystems).
Fluorescent Imaging
For membrane ruffling, cells were transfected with pEGFP-CaSR, and actin
was visualized with Phalloidin-594 (Molecular Probes) following treatment
with 0, 5, and 10 mM Ca2+e. Cells were imaged on a Nikon Eclipse E400
wide-field microscope using adapted protocols (Bouschet et al., 2007; Davey
et al., 2012). Single-cell microfluorimetry experiments were performed in
AP2s-WT or mutant cells transiently transfected with pEGFP-CaSR. Cells
were loaded with Fura-2 (Molecular Probes) for 30 min and imaged on a Nikon
TE2000 inverted microscope. Cells were perfused with extracellular bath solu-
tion with increasing CaCl2 concentrations. Fura-2 images were acquired using
340/380 nm excitation and 510 nm emission on mManager software (NIH).
Methods for TIRF microscopy were adapted from previous studies (Grant
et al., 2011; Hoppa et al., 2009). Images were obtained with an Olympus
IX-81 TIRF microscope. To monitor CaSR internalization, cells were pre-incu-
bated with BTx-594 and then perfused with 0.1 or 10 mM CaCl2 imaging solu-
tion. Images were captured at 10 frames/s in BSEP studies and 3 frames/s
for clathrin studies. Images were acquired using Cell^ R software (Olympus).
Confocal imaging was performed in HEK293 cells using methods adapted
from previous studies (Bouschet et al., 2007; Hanyaloglu et al., 2005). Images
were captured using a confocal, laser-scanning microscope (Leica SP5). All
images were analyzed using ImageJ (NIH).
Statistical Analysis
Two-tailed unpaired t test, two-way ANOVA, c2 test, Mann-Whitney U test,
Pearson’s correlation coefficient, and F test were used to calculate
statistical significance using GraphPad Prism 6 software. A p value < 0.05
was considered statistically significant. Statistical tests used are indicated
in the methods in the Supplemental Experimental Procedures and figure
legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
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ACKNOWLEDGMENTS
This work was supported by grants from the Medical Research Council
(G1000467 to C.M.G. and R.V.T.), National Institute for Health Research
(NIHR) Oxford Biomedical Research Centre (to R.V.T.), Shriners Hospitals for
Children (to M.P.W.), and a Goodger and Schorstein Scholarship from the
Radcliffe Department of Medicine, University of Oxford (to C.M.G.). R.V.T.
has Senior Investigator Awards from the Wellcome Trust (106995/z/15/z)
and NIHR (NF-SI-0514-10091). A.R. was a Wellcome Trust Clinical Training
Fellow.
AUTHOR CONTRIBUTIONS
C.M.G., B.H., A.I.T., A.C.H., and R.V.T. designed experiments; M.P.W.,
A.C.H., G.E.B., P.R., and R.V.T. provided materials; C.M.G., A.R., M.F., S.S.,
and A.C.H. performed experiments and analyzed data; C.M.G., A.C.H., and
R.V.T. wrote the manuscript; C.M.G., B.H., A.I.T., A.R., M.F., S.S., A.I.,
M.P.W., A.C.H., G.E.B., and R.V.T. reviewed and edited the manuscript.
DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: June 16, 2017
Revised: November 30, 2017
Accepted: December 22, 2017
Published: January 23, 2018
REFERENCES
Avlani, V.A., Ma, W., Mun, H.C., Leach, K., Delbridge, L., Christopoulos, A.,
and Conigrave, A.D. (2013). Calcium-sensing receptor-dependent activation
of CREB phosphorylation in HEK293 cells and human parathyroid cells. Am.
J. Physiol. Endocrinol. Metab. 304, E1097–E1104.
Bouschet, T., Martin, S., Kanamarlapudi, V., Mundell, S., and Henley, J.M.
(2007). The calcium-sensing receptor changes cell shape via a beta-arrestin-
1 ARNO ARF6 ELMO protein network. J. Cell Sci. 120, 2489–2497.
Calebiro, D., Nikolaev, V.O., Gagliani, M.C., de Filippis, T., Dees, C., Tacchetti,
C., Persani, L., and Lohse, M.J. (2009). Persistent cAMP-signals triggered by
internalized G-protein-coupled receptors. PLoS Biol. 7, e1000172.
Chakravarti, B., Chattopadhyay, N., and Brown, E.M. (2012). Signaling through
the extracellular calcium-sensing receptor (CaSR). In Advances in Experi-
mental Medicine and Biology, C. Signaling and M.S. Islam, eds. (Springer),
pp. 103–142.
Clague, M.J., and Urbe´, S. (2001). The interface of receptor trafficking and sig-
nalling. J. Cell Sci. 114, 3075–3081.
Conigrave, A.D., and Ward, D.T. (2013). Calcium-sensing receptor (CaSR):
pharmacological properties and signaling pathways. Best Pract. Res. Clin. En-
docrinol. Metab. 27, 315–331.
Davey, A.E., Leach, K., Valant, C., Conigrave, A.D., Sexton, P.M., and Christo-
poulos, A. (2012). Positive and negative allosteric modulators promote biased
signaling at the calcium-sensing receptor. Endocrinology 153, 1232–1241.
Davies, S.L., Gibbons, C.E., Vizard, T., and Ward, D.T. (2006). Ca2+-sensing
receptor induces Rho kinase-mediated actin stress fiber assembly and altered
cell morphology, but not in response to aromatic amino acids. Am. J. Physiol.
Cell Physiol. 290, C1543–C1551.
Devost, D., Sleno, R., Pe´trin, D., Zhang, A., Shinjo, Y., Okde, R., Aoki, J., Inoue,
A., and He´bert, T.E. (2017). Conformational profiling of the AT1 angiotensin II
receptor reflects biased agonism, G protein coupling, and cellular context.
J. Biol. Chem. 292, 5443–5456.
Feinstein, T.N., Yui, N., Webber, M.J., Wehbi, V.L., Stevenson, H.P., King, J.D.,
Jr., Hallows, K.R., Brown, D., Bouley, R., and Vilardaga, J.P. (2013). Nonca-
nonical control of vasopressin receptor type 2 signaling by retromer and ar-
restin. J. Biol. Chem. 288, 27849–27860.
Ferrandon, S., Feinstein, T.N., Castro, M., Wang, B., Bouley, R., Potts,
J.T., Gardella, T.J., and Vilardaga, J.P. (2009). Sustained cyclic AMP pro-
duction by parathyroid hormone receptor endocytosis. Nat. Chem. Biol. 5,
734–742.Galperin, E., and Sorkin, A. (2003). Visualization of Rab5 activity in living cells
by FRET microscopy and influence of plasma-membrane-targeted Rab5 on
clathrin-dependent endocytosis. J. Cell Sci. 116, 4799–4810.
Gao, Z.G., and Jacobson, K.A. (2016). On the selectivity of the Gaq inhibitor
UBO-QIC: a comparison with the Gai inhibitor pertussis toxin. Biochem. Phar-
macol. 107, 59–66.
Goltzman, D., and Hendy, G.N. (2015). The calcium-sensing receptor in
bone—mechanistic and therapeutic insights. Nat. Rev. Endocrinol. 11,
298–307.
Gorvin, C.M., Wilmer, M.J., Piret, S.E., Harding, B., van den Heuvel, L.P.,
Wrong, O., Jat, P.S., Lippiat, J.D., Levtchenko, E.N., and Thakker, R.V.
(2013). Receptor-mediated endocytosis and endosomal acidification is
impaired in proximal tubule epithelial cells of Dent disease patients. Proc.
Natl. Acad. Sci. USA 110, 7014–7019.
Gorvin, C.M., Hannan, F.M., Howles, S.A., Babinsky, V.N., Piret, S.E., Rogers,
A., Freidin, A.J., Stewart, M., Paudyal, A., Hough, T.A., et al. (2017). Ga11 mu-
tation in mice causes hypocalcemia rectifiable by calcilytic therapy. JCI Insight
2, e91103.
Grant, M.P., Stepanchick, A., Cavanaugh, A., and Breitwieser, G.E. (2011).
Agonist-driven maturation and plasma membrane insertion of calcium-
sensing receptors dynamically control signal amplitude. Sci. Signal. 4, ra78.
Hannan, F.M., Babinsky, V.N., and Thakker, R.V. (2016). Disorders of the cal-
cium-sensing receptor and partner proteins: insights into the molecular basis
of calcium homeostasis. J. Mol. Endocrinol. 57, R127–R142.
Hanyaloglu, A.C., McCullagh, E., and von Zastrow, M. (2005). Essential role of
Hrs in a recycling mechanism mediating functional resensitization of cell
signaling. EMBO J. 24, 2265–2283.
Hofer, A.M., Curci, S., Doble, M.A., Brown, E.M., and Soybel, D.I. (2000). Inter-
cellular communication mediated by the extracellular calcium-sensing recep-
tor. Nat. Cell Biol. 2, 392–398.
Holstein, D.M., Berg, K.A., Leeb-Lundberg, L.M., Olson, M.S., and Saunders,
C. (2004). Calcium-sensing receptor-mediated ERK1/2 activation requires
Galphai2 coupling and dynamin-independent receptor internalization.
J. Biol. Chem. 279, 10060–10069.
Hoppa, M.B., Collins, S., Ramracheya, R., Hodson, L., Amisten, S., Zhang, Q.,
Johnson, P., Ashcroft, F.M., and Rorsman, P. (2009). Chronic palmitate expo-
sure inhibits insulin secretion by dissociation of Ca(2+) channels from secre-
tory granules. Cell Metab. 10, 455–465.
Huang, C., Hujer, K.M., Wu, Z., and Miller, R.T. (2004). The Ca2+-sensing re-
ceptor couples to Galpha12/13 to activate phospholipase D in Madin-Darby
canine kidney cells. Am. J. Physiol. Cell Physiol. 286, C22–C30.
Irannejad, R., Tomshine, J.C., Tomshine, J.R., Chevalier, M., Mahoney, J.P.,
Steyaert, J., Rasmussen, S.G., Sunahara, R.K., El-Samad, H., Huang, B.,
and von Zastrow, M. (2013). Conformational biosensors reveal GPCR signal-
ling from endosomes. Nature 495, 534–538.
Jean-Alphonse, F., Bowersox, S., Chen, S., Beard, G., Puthenveedu, M.A.,
and Hanyaloglu, A.C. (2014). Spatially restricted G protein-coupled receptor
activity via divergent endocytic compartments. J. Biol. Chem. 289, 3960–3977.
Katritch, V., Cherezov, V., and Stevens, R.C. (2013). Structure-function of the
G protein-coupled receptor superfamily. Annu. Rev. Pharmacol. Toxicol. 53,
531–556.
Kelly, B.T., McCoy, A.J., Spa¨te, K., Miller, S.E., Evans, P.R., Ho¨ning, S., and
Owen, D.J. (2008). A structural explanation for the binding of endocytic dileu-
cine motifs by the AP2 complex. Nature 456, 976–979.
Kifor, O., MacLeod, R.J., Diaz, R., Bai, M., Yamaguchi, T., Yao, T., Kifor, I., and
Brown, E.M. (2001). Regulation of MAP kinase by calcium-sensing receptor in
bovine parathyroid and CaR-transfected HEK293 cells. Am. J. Physiol. Renal
Physiol. 280, F291–F302.
Kotowski, S.J., Hopf, F.W., Seif, T., Bonci, A., and von Zastrow, M. (2011).
Endocytosis promotes rapid dopaminergic signaling. Neuron 71, 278–290.
Mamillapalli, R., VanHouten, J., Zawalich, W., and Wysolmerski, J. (2008).
Switching of G-protein usage by the calcium-sensing receptor reverses itsCell Reports 22, 1054–1066, January 23, 2018 1065
effect on parathyroid hormone-related protein secretion in normal versus
malignant breast cells. J. Biol. Chem. 283, 24435–24447.
Nesbit, M.A., Hannan, F.M., Howles, S.A., Babinsky, V.N., Head, R.A., Cran-
ston, T., Rust, N., Hobbs, M.R., Heath, H., 3rd, and Thakker, R.V. (2013a). Mu-
tations affecting G-protein subunit a11 in hypercalcemia and hypocalcemia.
N. Engl. J. Med. 368, 2476–2486.
Nesbit, M.A., Hannan, F.M., Howles, S.A., Reed, A.A., Cranston, T., Thakker,
C.E., Gregory, L., Rimmer, A.J., Rust, N., Graham, U., et al. (2013b). Mutations
in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nat. Genet. 45,
93–97.
Newey, P.J., Gorvin, C.M., Cleland, S.J., Willberg, C.B., Bridge, M., Azharud-
din, M., Drummond, R.S., van der Merwe, P.A., Klenerman, P., Bountra, C.,
and Thakker, R.V. (2013). Mutant prolactin receptor and familial hyperprolac-
tinemia. N. Engl. J. Med. 369, 2012–2020.
Parkinson, D.B., and Thakker, R.V. (1992). A donor splice site mutation in the
parathyroid hormone gene is associated with autosomal recessive hypopara-
thyroidism. Nat. Genet. 1, 149–152.
Pi, M., Spurney, R.F., Tu, Q., Hinson, T., and Quarles, L.D. (2002). Calcium-
sensing receptor activation of rho involves filamin and rho-guanine nucleotide
exchange factor. Endocrinology 143, 3830–3838.
Quinn, S.J., Bai, M., and Brown, E.M. (2004). pH sensing by the calcium-
sensing receptor. J. Biol. Chem. 279, 37241–37249.
Rappoport, J.Z., and Simon, S.M. (2003). Real-time analysis of clathrin-medi-
ated endocytosis during cell migration. J. Cell Sci. 116, 847–855.
Riccardi, D., Brennan, S.C., and Chang, W. (2013). The extracellular calcium-
sensing receptor, CaSR, in fetal development. Best Pract. Res. Clin. Endocri-
nol. Metab. 27, 443–453.1066 Cell Reports 22, 1054–1066, January 23, 2018Rosenbaum, D.M., Rasmussen, S.G., and Kobilka, B.K. (2009). The structure
and function of G-protein-coupled receptors. Nature 459, 356–363.
Rossol, M., Pierer, M., Raulien, N., Quandt, D., Meusch, U., Rothe, K., Schu-
bert, K., Scho¨neberg, T., Schaefer, M., Kr€ugel, U., et al. (2012). Extracellular
Ca2+ is a danger signal activating the NLRP3 inflammasome through G pro-
tein-coupled calcium sensing receptors. Nat. Commun. 3, 1329.
Stauffer, T.P., Ahn, S., and Meyer, T. (1998). Receptor-induced transient
reduction in plasmamembrane PtdIns(4,5)P2 concentrationmonitored in living
cells. Curr. Biol. 8, 343–346.
Stenmark, H., Parton, R.G., Steele-Mortimer, O., L€utcke, A., Gruenberg, J.,
and Zerial, M. (1994). Inhibition of rab5 GTPase activity stimulates membrane
fusion in endocytosis. EMBO J. 13, 1287–1296.
Tojkander, S., Gateva, G., and Lappalainen, P. (2012). Actin stress fibers—as-
sembly, dynamics and biological roles. J. Cell Sci. 125, 1855–1864.
Wehbi, V.L., Stevenson, H.P., Feinstein, T.N., Calero, G., Romero, G., and Vi-
lardaga, J.P. (2013). Noncanonical GPCR signaling arising from a PTH recep-
tor-arrestin-Gbg complex. Proc. Natl. Acad. Sci. USA 110, 1530–1535.
Yarova, P.L., Stewart, A.L., Sathish, V., Britt, R.D., Jr., Thompson, M.A.,
Lowe, A.P.P., Freeman, M., Aravamudan, B., Kita, H., Brennan, S.C.,
et al. (2015). Calcium-sensing receptor antagonists abrogate airway hyper-
responsiveness and inflammation in allergic asthma. Sci. Transl. Med. 7,
284ra260.
Zietek, T., and Daniel, H. (2015). Intestinal nutrient sensing and blood glucose
control. Curr. Opin. Clin. Nutr. Metab. Care 18, 381–388.
